FDA Investigator: Amanda Lewin
- Amanda Lewin first started conducting FDA inspections in 2017, with the last inspection in 2020. Over that time, Amanda Lewin has conducted 28 inspections at 28 companies across 28 sites.
Get Amanda Lewin's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Kyowa Kirin Pharmaceutical Research, Inc., La Jolla | 2020
Out-of-stock
Amanda Lewin
Human Drug Form 483
FDA 483 Lambda Therapeutic Research Ltd., Ahmedabad | 2020
Out-of-stock
Amanda Lewin
Human Drug Form 483
FDA 483 Dana-Farber Harvard Cancer Center, Boston | 2018
Out-of-stock
Amanda Lewin
Human Drug Form 483
Co-Investigators (17)
- Sherri N. Rohlf, FDA Investigator
- Melkamu Getie Kebtie, FDA Investigator
- Getie Kebtie, Melkamu, FDA Investigator
- Makini Cobourne-Duval, FDA Investigator
- Lori Gioia, FDA Investigator
- Gajendiran Mahadevan, FDA Investigator
- Hasan A. Irier, FDA Investigator
- Courtney N. Long, FDA Investigator
- Joseph L. Despins, FDA Investigator
- Li-Hong P. Yeh, FDA Investigator
- Li-Hong Yeh, FDA Investigator
- Kara A. Scheibner, FDA Investigator
- Gopa Biswas, FDA Investigator
- Yiyue Zhang, FDA Investigator
- Sripal R. Mada, FDA Investigator
- Thea C. Grome, FDA Investigator
- Xiaohan Cai, FDA Investigator